CRM & Client Engagement
Front Office Operations
Clinical Documentation
Clinical Care Tools
Workforce Management
Operations & Productivity
Revenue Cycle Management
Outcomes & Integrations
Reporting & Analytics
AI & Automation
Community & Outpatient
Residential & Inpatient
About Us
CareersMandatory Disclosures
Mandatory Disclosure Statement
This statement explains that EHRYourWay has been officially tested and certified under the ONC Health IT Certification Program, which means it meets federal standards for electronic health record (EHR) systems used by healthcare providers in the United States.
Certification ensures our software can securely store, exchange, and manage patient data in compliance with national regulations. It also confirms that EHRYourWay includes the required Standardized API for Patient and Population Services, so patients and authorized applications can securely access their health information.
This EHRYourWay IT Module is compliant with the ONC Health IT Certification Program and has been certified by an ONC-Authorized Certification Body (SLI Compliance) in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services.
This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
Certification Details
Developer: Adaptamed LLC
Product: EHRYourWay
Edition: 2015 Edition Cures Update
ONC-ACB: SLI Compliance
Certification ID: 15.02.05.1042.ADAP.01.01.0.211220
CHPL Listing: https://chpl.healthit.gov/#/listing/10757
Certification Date: 12/20/2021
Modules Tested: 170.315(a)(1) through 170.315(h)(1)
Clinical Quality Measures Tested: EHRYourWay was tested and certified for the following
Clinical Quality Measures (CQMs) under §170.315(c)(1)–(c)(3)
Criteria Certified:
| Criteria |
|---|
| 170.315(a)(1) – Computerized Provider Order Entry – Medications |
| 170.315(a)(3) – Computerized Provider Order Entry – Diagnostic Imaging |
| 170.315(a)(5) – Demographics |
| 170.315(a)(14) – Implantable Device List |
| 170.315(b)(2) – Clinical Information Reconciliation and Incorporation |
| 170.315(b)(10) – Electronic Health Information (EHI) Export |
| 170.315(c)(1) – Clinical Quality Measures – Record and Export |
| 170.315(c)(3) – Clinical Quality Measures – Report |
| 170.315(d)(2) – Auditable Events and Tamper-Resistance |
| 170.315(d)(4) – Amendments |
| 170.315(d)(6) – Emergency Access |
| 170.315(d)(8) – Integrity |
| 170.315(d)(10) – Auditing Actions on Health Information |
| 170.315(d)(13) – Multi-Factor Authentication |
| 170.315(e)(3) – Patient Health Information Capture |
| 170.315(f)(5) – Transmission to Public Health Agencies – Electronic Case Reporting |
| 170.315(g)(3) – Safety-Enhanced Design |
| 170.315(g)(5) – Accessibility-Centered Design |
| 170.315(g)(7) – Application Access – Patient Selection |
| 170.315(g)(10) – Standardized API for Patient and Population Services |
| 170.315(a)(2) – Computerized Provider Order Entry – Laboratory |
| 170.315(a)(4) – Drug-Drug, Drug-Allergy Interaction Checks for CPOE |
| 170.315(a)(12) – Family Health History |
| 170.315(b)(1) – Transitions of Care |
| 170.315(b)(3) – Electronic Prescribing |
| 170.315(b)(11) – Decision Support Interventions |
| 170.315(c)(2) – Clinical Quality Measures – Import and Calculate |
| 170.315(d)(1) – Authentication, Access Control, and Authorization |
| 170.315(d)(3) – Audit Report(s) |
| 170.315(d)(5) –Automatic Access Timeout |
| 170.315(d)(7) – End-User Device Encryption |
| 170.315(d)(9) – Trusted Connection |
| 170.315(d)(12) – Encrypt Authentication Credentials |
| 170.315(e)(1) – View, Download, and Transmit to 3rd Party |
| 170.315(f)(1) – Transmission to Immunization Registries |
| 170.315(g)(2) – Automated Measure Calculation |
| 170.315(g)(4) – Quality Management System |
| 170.315(g)(6) – Consolidated CDA Creation Performance |
| 170.315(g)(9) – Application Access – All Data Request |
| 170.315(h)(1) – Direct Project |
CQMs certified:
Note: 170.315.(c)(3) – Clinical quality measures — report Certification criteria version applies here.
| CMS ID | DESCRIPTION |
|---|---|
| CMS128v6 | Anti-depressant Medication Management |
| CMS146v6 | Appropriate Testing for Children with Pharyngitis |
| CMS154v6 | Appropriate Treatment for Children with Upper Respiratory Infection (URI) |
| CMS125v6 | Breast Cancer Screening |
| CMS124v6 | Cervical Cancer Screening |
| CMS177v6 | Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment |
| CMS117v6 | Childhood Immunization Status |
| CMS75v6 | Children Who Have Dental Decay or Cavities |
| CMS153v6 | Chlamydia Screening for Women |
| CMS50v6 | Closing the Referral Loop: Receipt of Specialist Report |
| CMS130v6 | Colorectal Cancer Screening |
| CMS165v6 | Controlling High Blood Pressure |
| CMS149v6 | Dementia: Cognitive Assessment |
| CMS159v6 | Depression Remission at Twelve Months |
| CMS160v6 | Depression Utilization of the PHQ-9 Tool |
| CMS131v6 | Diabetes: Eye Exam |
| CMS123v6 | Diabetes: Foot Exam |
| CMS122v6 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control ( > 9%) |
| CMS68v7 | Documentation of Current Medications in the Medical Record |
| CMS136v7 | Follow-up Care for Children Prescribed ADHD Medication (ADD) |
| CMS90v7 | Functional Status Assessments for Congestive Heart Failure |
| CMS135v6 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v6 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS164v6 | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet |
| CMS69v6 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
| CMS147v7 | Preventive Care and Screening: Influenza Immunization |
| CMS2v7 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
| CMS22v6 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented |
| CMS138v6 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
| CMS74v7 | Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists |
| CMS156v6 | Use of High-Risk Medications in the Elderly |
| CMS155v6 | Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents |
Costs and Limitations:
There are no additional fees or technical limitations that would prevent an end user from implementing, connecting, or exchanging health information in accordance with ONC certification criteria.
Access to the standardized API for patient and population services (§170.315(g)(10)) is included as part of the certified product.
Implementation, configuration, or data migration services may incur standard professional service fees, as outlined in customer agreements.